Clinical Trial

Assessment of Safety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study will evaluate the safety and performance of the Spatial StimeMD (SSMD) medical device in people with multiple sclerosis (MS). The SSMD device is intended to support patients through a non-invasive stimulation program. The study will assess changes in MS-related symptoms and physical function using clinical assessments and patient-reported outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-02.
Trial Details
NCT Number NCT07396922
Lead Sponsor Motion Informatics LTD
Conditions Stroke, TBI, Spinal Cord Injury, Peripheral Nerve Damage
Enrollment 120 participants
Start Date 2026-12-30
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-11